Renal cell carcinoma, especially the clear cell type, often gains access to large tumor-draining veins while the primary tumor is still intrarenal. 1, 2 This propensity for intravenous growth can be extensive, initially involving sinus veins, proceeding to the main renal vein, continuing into the vena cava, and on occasion, reaching the right ventricle. [3] [4] [5] This impressive tendency for intravenous growth can also involve the renal venous system in regions of the kidney distant from the primary tumor. When this occurs it may not always be recognized as an intravenous process. One author (SB) first recognized this phenomenon several years ago. It is briefly mentioned in two recent publications but has not been reported in detail. 6, 7 This study investigates the incidence and defines the gross and histological features of retrograde venous invasion.
Materials and methods
In all, 115 renal cell carcinomas accessioned from 2007 to 2011 at Louisiana State University Health Sciences Center Department of Pathology were reviewed. The tumors were handled in the gross pathology laboratory by one or both of the authors, and were opened through the venous system as previously described. 6 All cases were staged using the 2010 TNM staging schema. 8 Cases with retrograde cortical venous invasion were identified as part of an ongoing study of invasive pathways for renal cell carcinomas. This project received Institutional Review Board approval. Main renal vein invasion was defined as tumor in an enlarged vein visible at the renal hilum before opening the specimen. Retrograde venous invasion was defined as rounded or elongated nodules of tumor separated from the primary tumor by uninvolved renal parenchyma. Tumor nodules must be in a location that conforms to the normal venous outflow of the kidney, that is, between renal pyramids or at the cortical-medullary junction.
Two blocks of tissue from each case of retrograde venous invasion were stained with a short panel of histochemical and immunohistochemical stains in an attempt to demonstrate the intravascular nature of the tumor nodules. These stains included elastic van Gieson stain, Masson trichrome stain, desmin and CD31. Stained sections were reviewed for evidence of vein wall and endothelial cell lining.
Results
A total of 115 renal cell carcinomas were reviewed consisting of 72 cases of clear-cell renal cell carcinoma, 24 cases of papillary renal cell carcinoma, five cases of chromophobe renal cell carcinoma, six cases of renal cell carcinoma, unclassified and eight other types of renal cell carcinoma. Nine cases, seven clear cell carcinomas and two renal cell carcinomas, unclassified, demonstrated retrograde venous invasion representing 8% of all renal cell carcinomas and 22% of pT3 tumors (Table 1 ). All tumors with retrograde venous invasion showed involvement of renal sinus veins and the main renal vein. Three of nine tumors also extended into the vena cava (Table 2 ). This included two of three rightsided tumors but only one of six left-sided tumors. Tumor sizes ranged from 4.2 to 17 cm (Table 2) . Tumors were aggressive in five patients with metastatic disease at time of nephrectomy to lung (three cases), lymph nodes (three cases), bone (one case) and adrenal (one case). Two of the four remaining cases had no followup and the remaining two cases had only a short followup of 1 and 4.5 months, respectively.
In all cases with retrograde venous invasion the unopened nephrectomy specimen had grossly obvious main renal vein involvement. By opening the specimens through the venous system, contiguous venous involvement from the main renal vein to the primary tumor was evident (Figures 1 and 2 ). In addition, contiguous venous involvement from the main renal vein to sinus veins, and proximal, to veins exiting the cortex from non-tumorous areas was readily visible in 7/9 cases (Figures 1 and 2) . In two cases additional parallel sections were required to clearly demonstrate the process (Figure 3) .
In all cases multiple sinus veins were involved. Retrograde venous invasion was most often observed in renal lobes adjacent to the primary tumor, but was also in observed distant poles in several cases (Figure 4a ). When retrograde venous invasion was extensive the intravenous tumor nodules involved the entire kidney ( Figure 5 ). In all cases rounded or elongated 0.1-1.0 cm sized nodules were visible between renal pyramids or arrayed along the . In addition, some cases showed cortical nodules consistent with interlobular vein involvement. As the intravenous nodules closest to the primary tumor enlarged they became confluent, coalescing into a multinodular mass making discrimination of the limits of the primary tumor from adjacent retrograde venous invasion challenging ( Figure 5 ). In some cases the intravenous tumor was a different color than the primary tumor, or was viable while the primary tumor was necrotic aiding gross recognition (Figures 2 and 3 ). Microscopically, retrograde venous invasion was recognized by the combination of location, relationships and evidence of pre-existing vein. Location refers to the presence of tumor nodules between renal pyramids or bracketed by renal medulla and cortex, the normal location of intralobar and arcuate veins (Figures 4b, 6 and 7) . Tumor extending from arcuate veins into one or more interlobular vein tributaries, was frequently identified (Figure 8 ). Relationship refers to the frequent presence of an artery adjacent to rounded tumor nodules, pertinent because renal arteries travel parallel to renal veins ( Figures 6 and 7) . When tumor nodules were small involving arcuate and intralobular veins, there was often a zone of separation between tumor and the vein wall, an obvious endothelial cell lining visible (Figures 4b, 8 and 9 ).
Identification of a pre-existing vein structure was impossible when an endothelial-lined zone of separation between tumor and vein wall was absent, as renal parenchymal veins lack appreciable smooth muscle media or elastica. 1 This was affirmed with Masson trichrome and elastic stains and with staining for desmin. When retrograde venous invasion involved intralobar veins between the renal pyramids, a short interrupted segment of apparent vein wall smooth muscle media could be demonstrated by trichrome and desmin stains in some cases. However, when tumor involved arcuate veins and cortical interlobular veins, no vein wall smooth muscle media was ever apparent (Figure 10) . Similarly, elastic stains failed to highlight a venous structure in any sized vein (Figure 11) .
Trichrome and elastic stain demonstrated extensive interstitial fibrosis adjacent to the tumor nodules and extending some distance throughout the cortex (Figure 11 ). This tubulointerstitial scarring is likely the result of chronic venous outflow obstruction. Desmin and trichrome stains allowed demonstration of feeder vessels, presumably recruited from pre-existing parenchymal vessels. These vessels entered the intravenous tumor at numerous points along its course as previously described.
1
CD31 was the most useful stain in demonstration of the intravenous nature of tumor nodules. CD31 often showed a complete or partial retention of an endothelial cell lining surrounding the intravenous tumor (Figures 12a and b) . In cases of clear cell carcinoma, CD31 highlighted a delicate capillary lattice within the intravenous tumor, definitional of clear cell carcinoma by World Health Organization criteria. 9 As nodules of retrograde venous invasion progressively enlarged, tumor becomes apposed to the vein wall obliterating the endothelial cell lining.
Tumor could then be observed extending into the renal parenchyma in sites lacking a CD31-positive endothelial lining ( Figure 13) .
The intravenous tumor regardless of the degree of venous enlargement or the caliber of vein involved, from the main renal vein to interlobular veins, invariably contained largely viable tumor. Focal necrosis was observed in a single case of renal cell carcinoma, unclassified (Figure 8 ). Significant thrombosis was not present in any case. When thrombus was present it was limited to a thin layer at the edge or at the leading front of intravenous tumor. In other words tumor thrombus, a reference commonly made to intravenous tumor, is not an accurate representation of the intravenous process. As the cortical nodules enlarged tumor invaded the interstitium and the nodules coalesced into multinodular masses. Demonstration of the intravenous origin of these confluent nodules became impossible but was inferred by examination of adjacent, as yet, not confluent intravenous nodules.
Discussion
Retrograde venous invasion has been briefly mentioned in the renal cell carcinoma literature, and therefore, is a process that may not be widely recognized. 5, 6 A recent case report contained a beautiful gross photograph of a nephrectomy specimen that we regard as showing retrograde venous invasion. 10 It was correctly interpreted as an 'infiltrative' process but its intrinsic venous nature was not mentioned. This study of retrograde venous invasion was designed to investigate this process in greater detail.
Retrograde venous involvement occurred in approximately 10% of all tumors and 22% of pT3a tumors. This process reflects aggressive behavior, as five of nine cases presented with metastatic disease. The majority of tumors were clear-cell renal cell carcinomas, not surprising in light of its remarkable diathesis for venous invasion. Although the only other category of tumor with retrograde venous invasion was renal cell carcinoma, unclassified, one author (SB) has seen 12 other cases of retrograde venous invasion not included in this study, as they were not sampled specifically for this finding. This group included cases of papillary renal cell carcinoma. Presumably, this phenomenon may occur with any tumor that shows extensive renal sinus vein and main renal vein involvement. If so, any renal cell carcinoma type, even urothelial carcinoma may, on occasion, shows retrograde venous invasion.
Retrograde venous invasion was only observed when both renal sinus veins and the main renal vein were involved. This suggests that retrograde venous growth is not favored until the elongating plug of intravenous tumor has occluded the venous outflow from veins draining non-tumor regions of the kidney. Presumably tumor can then extend proximally into sinus venous tributaries that merge with veins draining the primary tumor. Growth may be favored at these sites of least resistance, as blood flow in these veins would be absent or negligible. Although to date it has not been identified, it is possible that tumor may show retrograde venous invasion without sinus vein and main renal vein involvement, as there is extensive collateral venous communication between arcuate venous systems of adjacent renal lobes. 11, 12 The literature on pT3a/b renal cell carcinoma involving renal vein and vena cava, especially the urology and radiology literature, consistently refers to intravenous tumor as tumor 'thrombus'. 3, 4 This and a previous study have demonstrated that socalled tumor 'thrombus' is largely and often entirely a cylinder of solid viable tumor in direct continuity with the primary tumor. 1 The word tumor thrombus is misleading and we recommend that its use be discontinued.
Identification of retrograde venous invasion is usually straightforward once familiar with this phenomena, the purpose of this report. It is easiest to recognize on gross examination of the bivalved specimen. Recognition is facilitated if the bivalve step is performed along the venous system but requires understanding of the normal renal venous outflow. The normal venous outflow begins with cortical interlobular veins, which empty into arcuate veins at the corticomedullary junction. These converge with other arcuate veins and exit the renal parenchyma between renal pyramids. Thus, nodules of tumor located between renal pyramids and arrayed along the corticomedullary junction in cases with main renal vein involvement likely represent retrograde venous invasion. Histological demonstration of retrograde venous invasion is challenged by the absence of smooth muscle media or elastica in the normal venous outflow of the kidney. Although the endothelial lining of involved veins can be demonstrated by CD31 stain in some affected vessels, its presence is effaced as intravenous tumor enlarges and invades the interstitium. The rounded contour and presence of an adjacent artery are useful but non-specific findings that imply an intravenous origin of the nodules.
Once affected parenchymal veins become massively dilated, tumor attaches to the vein wall obliterating the endothelial lining. Invasion through the vein wall may then occur with confluence of originally intravenous tumor nodules. This confluence makes recognition of its intravenous history difficult as such nodules merge with the primary tumor. This confluence and merger of intravenous nodules could falsely exaggerate the size of the primary tumor and may explain why many renal cell carcinoma, particularly clear-cell carcinoma, commonly have a multinodular gross appearance.
We recommend that retrograde venous invasion should be carefully considered when renal cell carcinoma involves the main renal vein. If retrograde venous invasion or sinus vein invasion is identified it should be excluded from measurement of the primary tumor size. If argued otherwise, then by extrapolation main renal vein and vena cava invasion should be included in primary tumor size measurement, an illogical concept. As retrograde venous invasion may not be widely recognized studies that correlate tumor size with outcome may have included cases of pT3 tumors in which primary tumor size was overestimated. The worsening prognosis documented with increasing tumor size may partially reflect the poor prognosis of tumors with intravenous invasion. [13] [14] [15] [16] [17] [18] In summary, we describe the gross and microscopical features of retrograde venous invasion by renal cell carcinoma, an invasive process that may be under-recognized. Retrograde venous invasion is most common in clear-cell renal cell carcinoma, but should be considered in any tumor type when the main renal vein is involved. Opening tumor nephrectomies through the venous system coupled with knowledge of the normal venous outflow of the kidney, allows most cases to be recognized before microscopical evaluation. In cases with extensive retrograde venous invasion intravenous tumor nodules can become large and achieve confluent growth, making accurate determination of primary tumor size difficult. If tumor size is to remain a valid prognostic and staging parameter, accurate measurements are mandatory; otherwise, large tumor size becomes a surrogate marker for invasive growth, especially in cases of clear-cell carcinoma where intravenous invasion is so common.
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